Etanercept as Treatment for Still's Disease in Adults

Enbrel (Etanercept) Maintains Suppression Of Joint Pain, Swelling After Four Years

Etanercept: Long-Term Safety Update

Health Canada Approves Enbrel for the Treatment of  Moderately To Severely Active Rheumatoid Arthritis

ENBREL(R) (etanercept) Shown to Delay Structural Damage in Patients With Moderately to Severely Active Rheumatoid Arthritis

Etanercept(Enbrel) Curbs Early Rheumatoid Arthritis

ACR: Etanercept Improves Disease Activity In Ankylosing Spondylitis

FDA OKs Arthritis Drug for Children  

Back ] Up ] Next ]                                       


The materials and information on this server are intended for educational and informational purposes only. The materials and information are not intended to replace the services of a trained health professional or to be a substitute for medical advice of physicians and/or other health care professionals. The International Still's Disease Foundation is not engaged in rendering medical or professional medical services. You should consult your physician on specific medical questions, particularly in matters requiring diagnosis or medical attention. The International Still's Disease Foundation makes no representations or warranties with respect to any treatment, action, application medication or preparation by any person following the information offered or provided within this website.  Any information used from other websites was done so with permission from each site, with an exception to those of "public domain", whereas we believe any site without a cited reference was a "public domain site" and for our use.  The International Still's Disease Foundation is a non-profit organization.   This page was last updated on January 17, 2001

Copyrightę 1999-2001 International Still's Disease Foundation